[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366709-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366709-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","novel-curcumin-nanocarrier-for-targeting-drug-delivery-of-mitochondria-proves-efficacy-in-in-vivo-experiments-on-hepatocellular-carcinoma-mice-models","Novel curcumin nanocarrier for targeting drug delivery of mitochondria proves efficacy in in vivo experiments on hepatocellular carcinoma mice models","","Hepatocellular carcinoma is difficult to treat because systemic, non-selective therapies cause toxicity and often lead to relapse after tumor shrinkage. The study tests a strategy that targets mitochondria in cancer cells using a curcumin nanocarrier (TDC) built by modifying PAMAMG4 dendrimers with triphenylphosphonium for mitochondrial targeting. Results show altered cytokine release, stronger tumor-cell apoptosis signaling, increased ROS and apoptosis rates, and upregulation of bax and p53 with downregulation of bcl2, p21, and xiap. Ex vivo mitochondrial assays show changes in ATP, MDA, ROS, and reduced GSH, while biodistribution confirms higher accumulation in tumor and liver than free curcumin.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/novel-curcumin-nanocarrier-for-targeting-drug-delivery-of-mitochondria-proves-efficacy-in-in-vivo-experiments-on-hepatocellular-carcinoma-mice-models/366709/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/novel-curcumin-nanocarrier-for-targeting-drug-delivery-of-mitochondria-proves-efficacy-in-in-vivo-experiments-on-hepatocellular-carcinoma-mice-models/366709.png","ImageObject",300,407,{"name":42,"@type":43},"Fans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is hepatocellular carcinoma difficult to treat with current therapies?","Question",{"text":63,"@type":64},"Hepatocellular carcinoma remains challenging due to systemic toxicity from non-selective treatments. Tumor shrinkage is often followed by relapse until completion of therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the curcumin nanocarrier (TDC) target mitochondria?",{"text":68,"@type":64},"TDC is synthesized by modifying PAMAMG4 dendrimers with triphenylphosphonium (TPP). Mitochondrial targeting leverages the higher membrane potential of cancer cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports the anti-cancer efficacy of TDC in vivo?",{"text":72,"@type":64},"In tumor-positive groups, TDC increases the sub G1 cell population and elevates ROS and overall apoptosis rates by about 40–50%. It also shifts gene expression toward apoptosis (upregulating bax, p53; downregulating bcl2, p21, xiap) in cancerous liver tissues.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366709,1790831978,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nNovel curcumin nanocarrier for targeting drug delivery of mitochondria proves efficacy in in vivo experiments on hepatocellular carcinoma mice models  \nShahla Kianamiri1,2􀀍, Ehsan Shokri2, Parichehr Maleki3, Sara Soudi4, Hossein Soltaninejad5 & Majid Sadeghizadeh6􀀍  \nHepatocellular carcinoma (HCC) remains difficult to treat due to systemic toxicity of non-selective therapies. To address this, we hypothesized that targeting the highly active mitochondria of cancer cells, which have considerably increased membrane potential compared with normal cells, could bea promising approach to induce a stronger anticancer effect. Here, we report a curcumin nanocarrier (TDC) synthesized by modifying PAMAMG4 dendrimers with triphenylphosphonium (TPP). This design enables mitochondrial targeting, leveraging the elevated membrane potential of cancer cells to enhance curcumin’s anticancer activity. According to the results, the TDC influences the secreted levels of INF-γ and IL-4 on tumor lysis-stimulated splenocytes. In tumor-positive groups, TDC also increased cell population (sub G1 phase) 3.5 times, which was remarkable compared to healthy groups. Consistent with this, in tumor-positive mice, the amount of ROS and the overall rate ofTDC-induced apoptosis were increased by approximately 40–50% . In addition, TDC upregulates pro-apoptotic genes (bax, p53) and downregulates oncogenic genes (bcl2, p21, xiap) in the cancerous liver tissues, reflecting the anti-cancer effect of TDC as a mitochondria-targeted delivery system. Investigations conducted ex vivo on mitochondria isolated from liver and brain tissues revealed elevated levels of ATP, malonaldehyde (MDA), and reactive oxygen species (ROS), along with reduced glutathione (GSH) levels, all of which were linked to the process of apoptosis. Finally, the biodistribution findings indicate that the accumulation ofTDC in the tumor and liver was considerably greater than that of free curcumin (FC), likely due to the rapid elimination of FC at the concentration tested.  \nKeywords Curcumin nano carrier (TDC), Cytotoxicity, Hepatocellular carcinoma (HCC), Mitochondria targeting, Polyamidoamine dendrimer  \nThe incidence of Liver cancer as a global health challenge is growing worldwide1,2. The most prevalent form of liver cancer is hepatocellular carcinoma (HCC), which includes almost 90% of cases. Unfortunately, the current management of HCC is not adequate. Chemotherapy, surgery, and radiofrequency ablation are usually directed toward shrinking the tumor bulk, while in most cases, the tumor relapses until the completion of the therapy. Available chemotherapy reagents have been demonstrated to show severe toxicity and side effects. These side effects are mostly due to the non-targeting function of the utilized drugs directly against tumor cells.  \nIn this regard, the design and synthesis of targeting drugs employing natural phytocompounds with anticancer effects by considering minor physiological differences between cancer and normal cells would be helpful  \n1Nano-Biotechnology Department, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. 2 Department of Nanotechnology, Agricultural Biotechnology Research Institute of Iran (ABRII), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. 3Department of Molecular Medicine, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran. 4Immunology Department, Medical Sciences, Faculty Tarbiat Modares University, Tehran, Iran. 5Stem Cell Technology and Tissue Regeneration, Faculty of Interdisciplinary Scince and Technologies Tarbiat, Modares University, Tehran, Iran. 6Genetics Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran. 􀀍 email: [shahla.kianamiri@modares.ac.ir](shahla.kianamiri@modares.ac.ir); [sadeghma@modares.ac.ir](sadeghma@modares.ac.ir)  ","cbCaivAPOHiVk5Qx","https://ap.wps.com/l/cbCaivAPOHiVk5Qx","pdf",3520751,21,"English","# Overview\n## Problem and hypothesis\n## Curcumin nanocarrier design\n## Key experimental findings\n## Gene expression and apoptosis markers\n## Ex vivo mitochondrial analyses\n## Biodistribution and comparison with free curcumin","[{\"question\":\"Why is hepatocellular carcinoma difficult to treat with current therapies?\",\"answer\":\"Hepatocellular carcinoma remains challenging due to systemic toxicity from non-selective treatments. Tumor shrinkage is often followed by relapse until completion of therapy.\"},{\"question\":\"How does the curcumin nanocarrier (TDC) target mitochondria?\",\"answer\":\"TDC is synthesized by modifying PAMAMG4 dendrimers with triphenylphosphonium (TPP). Mitochondrial targeting leverages the higher membrane potential of cancer cells.\"},{\"question\":\"What evidence supports the anti-cancer efficacy of TDC in vivo?\",\"answer\":\"In tumor-positive groups, TDC increases the sub G1 cell population and elevates ROS and overall apoptosis rates by about 40–50%. It also shifts gene expression toward apoptosis (upregulating bax, p53; downregulating bcl2, p21, xiap) in cancerous liver tissues.\"}]","Novel curcumin nanocarrier for targeting drug delivery of mitochondria proves efficacy in in vivo experiments on hepatocellular carcinoma mice models | PDF",1790166804,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2a0b3b0c77e87727166cdb22b90d9ff.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a7a4faa084551569e9875bc09e33ad2.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08998ae593fc6a2f2e424f0b2773f16a.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffd2de0335dc16c64b3dd08946ff6d91.webp",980,1287]